Three Canadian Drug Companies Are Voluntarily Recalling All Lots of Their Antipsychotic Medication Due to Possible Contamination. At the request of Health Canada, Cobalt Pharmaceuticals Company, Laboratoires Riva Inc. and Sanis Health Inc. are voluntarily recalling all lots of Quetiapine, an anti-psychotic medication, because it may have been contaminated during the manufacturing process with Clindamycin, an antibiotic medication.
The recall is for all of the 25 mg, 100 mg, 200 mg and 300 mg doses of Co Quetiapine, Riva Quetiapine, and Sanis Quetiapine.
Quetiapine is an anti-psychotic medication, use to treat schizophrenia and bipolar disorder.
As of the time of this post there have been no reports of an adverse reaction because of the possible contamination.
Possible reaction to taking the contaminated medication could include:
- mild skin rashes
- skin disorders
- Stevens-Johnson syndrome
- anaphylactic reaction
- anaphylactic shock
If you or someone you know takes any of the medication recalled, Health Canada is asking you to:
- Contact your health care provider ASAP
- DO NOT discontinue taking the medication until speaking to your health care provider
- Report any and all possible reactions to Health Canada
- Contact Health Canada tool free with any questions or concerns regarding this recall at 1-800-267-9675
How to report side effects to health products: To report any possible reaction to this recall or other health products, please contact Health Canada toll-free at 1-866-234-2345, or complete a Reporting Form and send to Health Canada using one of the following methods:
- By Fax: 1-866-678-6789
- By Internet: www.healthcanada.gc.ca/medeffect
- By Mail: Canada Vigilance Program Marketed Health Products Directorate Ottawa, ON, Address Locator 0701E K1A 0K9